TY - JOUR T1 - Equivalence of an innovative multidose salmeterol/fluticasone dry powder inhaler vs comparator in paediatric asthma JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - P4296 AU - Piotr Kuna AU - Ingolf Gath AU - Ursula Thyroff-Friesinger AU - Spencer Jones Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/P4296.abstract N2 - This study evaluated efficacy and safety of an innovative dry powder inhaler (DPI – Sandoz) vs Seretide™ Accuhaler™ (GSK) containing 50 μg salmeterol and 100 μg fluticasone per actuation.A double-blind, double-dummy, multicentre, randomized, 2-arm parallel group study in children with persistent moderate asthma with a 2-week washout period and 12 weeks of active treatment; twice daily inhalation of a single actuation from an active and placebo device.The innovative DPI and Seretide™ Accuhaler™ gave comparable results in children (6–11 years) across all endpoints.View this table:The incidence of adverse events with a suspected drug relationship was very low and comparable between treatments. ER -